Tag results:
myocardial infarction
Human Immunology News
P2Y12 Receptor Blockers Are Anti-inflammatory Drugs Inhibiting Both Circulating Monocytes and Macrophages including THP-1 Cells
[Scientific Reports] The authors identified potential anti-inflammatory effects of P2Y12 receptor blockers on monocytes and macrophages.
Endothelial Cell News
Irisin Enhances Angiogenesis of Mesenchymal Stem Cells to Promote Cardiac Function in Myocardial Infarction via PI3k/Akt Activation
[International Journal of Stem Cells] Researchers investigated the potential role of irisin in the angiogenesis of bone-marrow mesenchymal stem cells (BMSCs). In vivo, irisin-treated BMSCs were transplanted into an myocardial infarction mouse model.
Endothelial Cell News
Knockdown of Salusin-β Improves Cardiovascular Function in Myocardial Infarction-Induced Chronic Heart Failure Rats
[Oxidative Medicine and Cellular Longevity] The authors investigated the effects of silencing salusin-β on endothelial function, cardiac function, vascular and myocardial remodeling, and its underlying signaling pathways in chronic heart failure rats induced by coronary artery ligation.
Muscle Cell News
Cardiac Toxicity from Bisphenol A Exposure in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes
[Toxicology and Applied Pharmacology] Researchers found that bisphenol A (BPA) exposure altered cardiac function in human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs). Acute BPA exposure in hiPSC-CMs resulted in reduced field potential, as measured by multielectrode array
Muscle Cell News
Combined Genetic and Chemical Screens Indicate Protective Potential for EGFR Inhibition to Cardiomyocytes under Hypoxia
[Scientific Reports] Scientists screened for targets for the treatment of ischemia–reperfusion injury using a combination of shRNA and drug library analyses in HL-1 mouse cardiomyocytes subjected to hypoxia and reoxygenation.
Muscle Cell News
Myocardial Fibrosis Reversion via rhACE2-Electrospun Fibrous Patch for Ventricular Remodeling Prevention
[NPJ Regenerative Medicine] By multiple in vitro studies, the rhACE2 patch demonstrated effectiveness in reducing cardiomyocytes apoptosis under hypoxia stress and inhibiting cardiac fibroblasts proliferation, which gave evidence for its in vivo efficacy.